Literature DB >> 26329483

Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.

Mahsa Hajivalili, Fatemeh Pourgholi, Hossein Samadi Kafil, Farhad Jadidi-Niaragh, Mehdi Yousefi1.   

Abstract

Amyotrophic lateral sclerosis (ALS is a neurodegenerative disorder which is characterized by motor neuron (MN dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.

Entities:  

Mesh:

Year:  2016        PMID: 26329483     DOI: 10.2174/1574888x10666150902095031

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  6 in total

Review 1.  Roles of exosomes in the normal and diseased eye.

Authors:  Mikael Klingeborn; W Michael Dismuke; Catherine Bowes Rickman; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2017-04-29       Impact factor: 21.198

Review 2.  Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.

Authors:  Jia Liu; Fei Wang
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

3.  Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death.

Authors:  Thangavelu Soundara Rajan; Francesca Diomede; Placido Bramanti; Oriana Trubiani; Emanuela Mazzon
Journal:  Int J Immunopathol Pharmacol       Date:  2017-11-15       Impact factor: 3.219

4.  Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells.

Authors:  Ioanna Christou; Panagiotis Mallis; Efstathios Michalopoulos; Theofanis Chatzistamatiou; George Mermelekas; Jerome Zoidakis; Antonia Vlahou; Catherine Stavropoulos-Giokas
Journal:  Bioengineering (Basel)       Date:  2018-02-26

5.  Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Anna Sobuś; Agnieszka Wełnicka; Agnieszka Meller; Karolina Machowska-Sempruch; Alicja Zawiślak; Karolina Łuczkowska; Sławomir Milczarek; Bogumiła Osękowska; Edyta Paczkowska; Iwona Rotter; Przemysław Nowacki; Bogusław Machaliński
Journal:  Stem Cells Int       Date:  2019-06-02       Impact factor: 5.443

6.  Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Ewa Pius-Sadowska; Zofia Litwińska; Maciej Kotowski; Agnieszka Meller; Iwona Rotter; Jarosław Peregud-Pogorzelski; Przemysław Nowacki
Journal:  Int J Med Sci       Date:  2020-07-19       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.